Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

E&C Panel Advances Measures To Speed Rare Disease Drug Development

The House Energy & Commerce health subcommittee on Thursday (May 16) passed a bill that aims to improve outcomes for children with rare cancers by incentivizing drug makers to conduct pediatric clinical trials when studying combinations of multiple cancer drugs.

Inside Drug Pricing Home Page


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.